DEA Bans Mysterious Ketamine Analog for Two Years
Published Date: 5/22/2026
Rule
Summary
Starting May 22, 2026, the DEA is putting 2-fluorodeschloroketamine (2-FDCK) into Schedule I, meaning it’s now treated like the most dangerous drugs. This affects anyone who makes, sells, or uses it, adding strict rules and serious penalties. The temporary ban lasts two years, giving the government time to decide if it should stay permanent.
Analyzed Economic Effects
7 provisions identified: 0 benefits, 6 costs, 1 mixed.
Immediate Schedule I Classification
Starting May 22, 2026, 2-fluorodeschloroketamine (2-FDCK) is temporarily placed in Schedule I of the Controlled Substances Act until May 22, 2028 (with a possible one-year extension). This subjects 2-FDCK (including its salts and isomers) to the strictest federal controls because DEA found it poses an imminent hazard to public safety.
DEA Registration Required to Handle 2-FDCK
As of May 22, 2026, anyone who handles (manufactures, distributes, imports/exports, researches, analyzes, or possesses) 2-FDCK must be registered with DEA under the Controlled Substances Act before continuing those activities. Persons currently handling 2-FDCK who are not registered must submit an application and may not continue handling the substance unless DEA approves the registration.
Manufacture, Import, and Quota Limits
Only DEA-registered manufacturers may produce 2-FDCK and only within quotas assigned by DEA under the CSA as of May 22, 2026. All importation and exportation must comply with DEA import/export regulations and order form requirements apply to distributors.
Surrender Stocks or Cease Handling
If you do not want or cannot obtain a Schedule I registration for 2-FDCK, you must surrender all quantities of the substance; continuing to possess or handle any quantity without authorization is unlawful as of May 22, 2026.
Unauthorized Handling: Criminal & Civil Risk
Any handling of 2-FDCK that is not authorized under the CSA on or after May 22, 2026 is unlawful and may subject the person to administrative, civil, and criminal sanctions under federal law.
90-Day Continuation for Certain Researchers
If, on May 22, 2026, you are conducting research on 2-FDCK and are already registered to research another Schedule I substance, you may continue that research provided you submit a completed application or modification to register for 2-FDCK within 90 calendar days of May 22, 2026. You may continue until the application is withdrawn or DEA moves to deny it.
Immediate Compliance Steps for Current Registrants
Current DEA registrants who possess any quantity of 2-FDCK must take an inventory on the effective date and will have 30 calendar days from May 22, 2026 to comply with labeling, packaging, recordkeeping, and record submission requirements. After the initial inventory, registrants must inventory controlled substances biennially.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-13821 — Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
The DEA wants to put tianeptine, a drug with potential risks, into Schedule I, meaning it’ll be treated like the most tightly controlled substances. This change affects anyone who makes, sells, studies, or uses tianeptine, bringing strict rules and penalties. You’ve got until August 7, 2026, to share your thoughts before the new rules could kick in.
2026-13705 — Importer of Controlled Substances Application: Benuvia Operations, LLC.
Benuvia Operations, LLC wants to become an official importer of certain controlled substances like marijuana extract and psilocybin. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 6, 2026. This move could shake up who gets to bring these substances into the U.S., so keep an eye on the deadline if you’re interested!
2026-13580 — Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
Starting July 6, 2026, the DEA plans to temporarily put 7-hydroxymitragynine above a certain amount into Schedule I, meaning it’s treated like the most tightly controlled drugs. This affects anyone who makes, sells, studies, or even just has this substance, bringing strict rules and penalties. The move aims to keep people safe while the government figures out the long-term plan.
2026-13581 — Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
Starting July 6, 2026, the DEA plans to temporarily put three substances related to 7-hydroxymitragynine—Mitragynine Pseudoindoxyl, MGM-15, and MGM-16—into Schedule I, the strictest drug category. This means anyone making, selling, or using these chemicals will face tough legal rules and penalties. The move aims to control these substances quickly while the DEA studies them further, affecting businesses and researchers handling these compounds.
Previous / Next Documents
Previous: 2026-10202 — Kentucky Regulatory Program
Kentucky’s surface mining rules just got a fresh update! The state fixed some old rules, removed temporary ones, and cleaned up wording to keep things clear and smooth. These changes kick in on June 22, 2026, affecting coal mining companies and regulators, but won’t cost anyone extra.
Next: 2026-10258 — Rescinding Portions of Department of the Interior Title VI Regulations To Conform More Closely With the Statutory Text and To Implement Executive Order 14281
The Department of the Interior is changing its rules to focus only on intentional discrimination, dropping parts that punished unintentional effects. This update, effective May 22, 2026, helps avoid legal problems, cuts red tape, and follows a new executive order. People and groups dealing with the Department will see simpler, clearer rules without extra costs or confusion.